MX2023004126A - Bioactive renal cells for the treatment of chronic kidney disease. - Google Patents

Bioactive renal cells for the treatment of chronic kidney disease.

Info

Publication number
MX2023004126A
MX2023004126A MX2023004126A MX2023004126A MX2023004126A MX 2023004126 A MX2023004126 A MX 2023004126A MX 2023004126 A MX2023004126 A MX 2023004126A MX 2023004126 A MX2023004126 A MX 2023004126A MX 2023004126 A MX2023004126 A MX 2023004126A
Authority
MX
Mexico
Prior art keywords
treatment
kidney disease
chronic kidney
renal cells
bioactive renal
Prior art date
Application number
MX2023004126A
Other languages
Spanish (es)
Inventor
Deepak Jain
Timothy A Bertram
Original Assignee
Timothy A Bertram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Timothy A Bertram filed Critical Timothy A Bertram
Priority to MX2023004126A priority Critical patent/MX2023004126A/en
Publication of MX2023004126A publication Critical patent/MX2023004126A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention concerns methods of using bioactive renal cell populations to provide regenerative effects to a native kidney for the treatment of chronic kidney disease.
MX2023004126A 2019-01-29 2019-01-29 Bioactive renal cells for the treatment of chronic kidney disease. MX2023004126A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2023004126A MX2023004126A (en) 2019-01-29 2019-01-29 Bioactive renal cells for the treatment of chronic kidney disease.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2023004126A MX2023004126A (en) 2019-01-29 2019-01-29 Bioactive renal cells for the treatment of chronic kidney disease.

Publications (1)

Publication Number Publication Date
MX2023004126A true MX2023004126A (en) 2023-04-27

Family

ID=89984246

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004126A MX2023004126A (en) 2019-01-29 2019-01-29 Bioactive renal cells for the treatment of chronic kidney disease.

Country Status (1)

Country Link
MX (1) MX2023004126A (en)

Similar Documents

Publication Publication Date Title
MX2019001257A (en) Bioactive renal cells for the treatment of chronic kidney disease.
SG10201803533YA (en) Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
TN2013000412A1 (en) Bcma-based stratification and therapy for multiple myeloma patients
EA201990293A1 (en) MULTI-SPECIFIC ANTIBODIES AGAINST CD40 AND CD137
UY34261A (en) FUNGICIDE COMPOUNDS OF 1- {2- [2-HALO-4- (4-HALOGEN-FENOXI) -FENIL] -2-ALCOXI-2-CICLIL-ETIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL
MX2016014248A (en) Polyfluorinated compounds acting as bruton's tyrosine kinase inhibitors.
UY34260A (en) FUNGICIDE COMPOUNDS OF 1- {2- [2-HALO-4- (4-HALOGEN-Phenoxy) -Phenyl] -2-ETOXI-ETIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL
UY34259A (en) FUNGICIDE COMPOUNDS OF 1- {2- [2-HALO-4- (4-HALOGEN-Phenoxy) -Phenyl] -2-ALCOXI-3-METHYL-BUTIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL
UY34258A (en) FUNGICIDE COMPOUNDS OF 1- {2- [2-HALO-4- (4-HALOGEN-Phenoxy) -Phenyl] -2-ALCOXI-2-ALQUINIL / ALQUENIL-ETIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL
MX2021004953A (en) Selection of improved tumor reactive t-cells.
MX339769B (en) Systems, methods and compositions for optimizing tissue and cell enriched grafts.
PH12017500586A1 (en) Methods of separating gemcitabine-phosphate diastereoisomers
EP3641811A4 (en) Immunoprivileged bioactive renal cells for the treatment of kidney disease
BR112017017886A2 (en) generating arterial endothelial cell populations
MX2015012729A (en) Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue.
GB201211349D0 (en) Redox battery use for Polyoxometallate
MX2020005640A (en) Humanized anti-liv1 antibodies for the treatment of breast cancer.
MX2021009967A (en) Methods for producing autologous t cells useful to treat cancers and compositions thereof.
MX2016016756A (en) Stem cell therapy in endometrial pathologies.
EA201791021A1 (en) 1- [2- (AMINOMETHYL) BENZYL] -2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO [3,2-d] PYRIMIDIN-4-ONE AS INHIBITORS MYELOPEROXIDASE
FR2973649B1 (en) THIXOTROPIC HYDROGELS BASED ON ALPHA-LACTALBUMIN, PROCESS FOR THEIR PREPARATION AND USES THEREOF
AR093527A1 (en) 6 - ((S) -1-1- [5- (2-HIDROXI-ETOXI) -PIRIDIN-2-IL] 1H-PIRAZOL-3-IL-ETIL) -3H-1,3-BENZOTIAZOL-2-ONA AS AN AMPA RECEIVER AMPA DEPENDENT OF TARP-g 8
MX2022005821A (en) Renal cell carcinoma (rcc) therapy using genetically engineered t cells targeting cd70.
CA188085S (en) Razor cartridge
EP4279925A3 (en) Dulaglutide for the treatment of chronic kidney disease